Figure 5. Changes in angiogenesis- and inflammation-related genes in PSP-treated CNV corneas. Compared with controls, the expressions of VEGF, MMP2, MMP9, SDF1, and TNF were reduced by 73%, 76%, 35%, 51%, and 64% respectively, while the expression of PEDF was increased by 76%. Red bars represent standard deviation, and blue bars represent a 95% confidence interval for the mean.